Literature DB >> 19403491

Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school.

Richard M Scheffler1, Timothy T Brown, Brent D Fulton, Stephen P Hinshaw, Peter Levine, Susan Stone.   

Abstract

OBJECTIVE: Approximately 4.4 million (7.8%) children in the United States have been diagnosed with attention-deficit/hyperactivity disorder, and 56% of affected children take prescription medications to treat the disorder. Attention-deficit/hyperactivity disorder is strongly linked with low academic achievement, but the association between medication use and academic achievement in school settings is largely unknown. Our objective was to determine if reported medication use for attention-deficit/hyperactivity disorder is positively associated with academic achievement during elementary school.
METHOD: To estimate the association between reported medication use and standardized mathematics and reading achievement scores for a US sample of 594 children with attention-deficit/hyperactivity disorder, we used 5 survey waves between kindergarten and fifth grade from the nationally representative Early Childhood Longitudinal Study--Kindergarten Class of 1998-1999 to estimate a first-differenced regression model, which controlled for time-invariant confounding variables.
RESULTS: Medicated children had a mean mathematics score that was 2.9 points higher than the mean score of unmedicated peers with attention-deficit/hyperactivity disorder. Children who were medicated for a longer duration (at >2 waves) had a mean reading score that was 5.4 points higher than the mean score of unmedicated peers with attention-deficit/hyperactivity disorder. The medication-reading association was lower for children who had an individualized education program than for those without such educational accommodation.
CONCLUSIONS: The finding of a positive association between medication use and standardized mathematics and reading test scores is important, given the high prevalence of attention-deficit/hyperactivity disorder and its association with low academic achievement. The 2.9-point mathematics and 5.4-point reading score differences are comparable with score gains of 0.19 and 0.29 school years, respectively, but these gains are insufficient to eliminate the test-score gap between children with attention-deficit/hyperactivity disorder and those without the disorder. Long-term trials are needed to better understand the relationship between medication use and academic achievement.

Entities:  

Mesh:

Year:  2009        PMID: 19403491     DOI: 10.1542/peds.2008-1597

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  41 in total

1.  Assessing racial/ethnic differences in the social consequences of early-onset psychiatric disorder.

Authors:  Benjamin Lê Cook; Nicholas Carson; Margarita Alegria
Journal:  J Health Care Poor Underserved       Date:  2010-05

Review 2.  Psychostimulants as cognitive enhancers: the prefrontal cortex, catecholamines, and attention-deficit/hyperactivity disorder.

Authors:  Craig W Berridge; David M Devilbiss
Journal:  Biol Psychiatry       Date:  2010-09-26       Impact factor: 13.382

3.  A randomized trial of two promising computer-based interventions for students with attention difficulties.

Authors:  David L Rabiner; Desiree W Murray; Ann T Skinner; Patrick S Malone
Journal:  J Abnorm Child Psychol       Date:  2010-01

4.  Do stimulant medications improve educational and behavioral outcomes for children with ADHD?

Authors:  Janet Currie; Mark Stabile; Lauren Jones
Journal:  J Health Econ       Date:  2014-05-16       Impact factor: 3.883

5.  Disease prioritarianism: a flawed principle.

Authors:  Karim Jebari
Journal:  Med Health Care Philos       Date:  2016-03

6.  Using ADHD Medications to Treat Coexisting ADHD and Reading Disorders: A Systematic Review.

Authors:  Tanya E Froehlich; Jason Fogler; William J Barbaresi; Nada A Elsayed; Steven W Evans; Eugenia Chan
Journal:  Clin Pharmacol Ther       Date:  2018-08-30       Impact factor: 6.875

Review 7.  Genetic Influence on Efficacy of Pharmacotherapy for Pediatric Attention-Deficit/Hyperactivity Disorder: Overview and Current Status of Research.

Authors:  Nada A Elsayed; Kaila M Yamamoto; Tanya E Froehlich
Journal:  CNS Drugs       Date:  2020-04       Impact factor: 5.749

Review 8.  Attention-deficit/hyperactivity disorder and risk of substance use disorder: developmental considerations, potential pathways, and opportunities for research.

Authors:  Brooke S G Molina; William E Pelham
Journal:  Annu Rev Clin Psychol       Date:  2014-01-15       Impact factor: 18.561

Review 9.  The cognition-enhancing effects of psychostimulants involve direct action in the prefrontal cortex.

Authors:  Robert C Spencer; David M Devilbiss; Craig W Berridge
Journal:  Biol Psychiatry       Date:  2014-09-28       Impact factor: 13.382

Review 10.  Impact of Attention-Deficit Hyperactivity Disorder on School Performance: What are the Effects of Medication?

Authors:  Raman Baweja; Richard E Mattison; James G Waxmonsky
Journal:  Paediatr Drugs       Date:  2015-12       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.